“2023 was another year of performance and progress for our company,” said Robert Bradway, chairman and CEO. “Our marketed products are reaching many more patients around the world, and we anticipate more than a dozen significant pipeline milestones in 2024.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMGN:
